Use of PPIs was associated with increased risks of first -time ischemic stroke and MI, particularly among long -term users and at high doses.
Compared with warfarin, treatment with DOACs was not associated with an increased risk of major bleeding or all-cause mortality within the first 90 days.
Compared with nonusers, current statin users experienced markedly decreased risk of CA-SAB.
Patients who discontinued aspirin use experience a higher risk of cardiovascular events.
The report addresses the appropriate use of multiple imaging modalities available for clinicians in the evaluation of valvular heart disease, discussing the spectrum of patients.
The researchers found no long-term increase in either all-cause or cause-specific mortality among women who received hormone therapy for up to 5.6 years or 7.2 years, depending on the type of therapy.
Compared with normal-weight individuals, metabolically healthy obese individuals have an increased risk of coronary heart disease, cerebrovascular disease, and heart failure
The statement includes advances in care since the ADA's last position statement was published in 2003.
NT-proBNP-guided treatment strategy did not improve outcomes compared with a usual care strategy in high-risk patients with heart failure.
The findings offer the first strong clinical evidence that inflammation-targeted therapy may reduce the risk of cardiovascular disease.
Men who are admitted to the hospital with a serious infection may have an increased risk of cardiovascular disease in the years immediately following the infection.
The AAP has released an updated clinical practice guideline for the diagnosis and management of high blood pressure in children.
Fondaparinux and rivaroxaban were associated with increased risk of major bleeding in patients who underwent total hip or knee arthroplasty.
Risk-adjusted in-hospital mortality is significantly increased at safety-net hospitals for patients undergoing percutaneous coronary intervention.
The incidence of all strokes decreased over time in men, but not women, due to a decrease in ischemic stroke.
Researchers found higher estimated cardiovascular risks associated with marijuana use than cigarette smoking.
The gene-editing tool called CRISPR-Cas9 could have the potential to treat and prevent other genetic diseases.
The USPSTF updated their 2012 recommendations on behavior lifestyle counseling for preventing cardiovascular disease.
Stopping statin therapy 3 to 6 months after an initial ischemic stroke may increase risk of a recurrent stroke.
A 30-year-old woman presents with an increased heart rate, shortness of breath, and tingling in her right arm.
Data from a clinical trial show that patients taking daily aspirin were not at heightened risk of being hospitalized for heart failure.
Adulthood weight gain is associated with an increased risk of major chronic diseases and mortality.
Researchers sought to examine the link between intelligence scores during childhood and leading causes of death during the life course.
The use of PAP, compared with no treatment or sham, was not associated with reduced risks of cardiovascular outcomes or death for patients with sleep apnea.
Researchers found that idarucizumab is effective for dabigatran reversal among patients with uncontrolled bleeding and who are undergoing urgent surgery.
Users of opioid-only agents had significantly increased rates of emergency room visits and hospitalizations for ischemic heart disease and IHD-related mortality.
Primary care providers can help significantly reduce heart failure exacerbations and improve their patients' overall quality of life.
There were 526.86 hospital admissions for every 100,000 people in 2002, compared with 364.66 per 100,000 in 2013.
Clinicians will encounter more patients at risk for CHF as the population ages and cardiovascular risk factors become more prevalent.
The researchers found that during 13,509 patient-years of follow-up, 3166 patients had 405 first bleeding events.